RLAY
Relay TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
RLAY vs peer average
37/100
RLAY vs. peer average (D vs. C)
Grade spread
A 2 · B 2 · C 2 · D 2 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
IDYA is the first available peer comparator.
IDEAYA is a closer small-cap precision-oncology development peer by stage and valuation, though its pipeline differs; peer sentiment helps frame how much RLAY still trades on milestone timing versus marketed-product economics.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
RLAY
Relay Therapeutics
IDYA
IDEAYA Biosciences
Grade
D
A
Momentum
97
86
Value
41
41
Sentiment
14
66
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs IDYA
RLAY / IDYA
Grade Position
Below peers
RLAY vs. peer average (D vs. C)
37/100
Momentum
97
RLAYValue
41
RLAYSentiment
14
IDYARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs RLAY
IDYA is the first peer returned for this comparison set.